ArticleBone marrow transplantation2025

Improved GVHD-free and relapse-free survival after ex vivo αβTCR and CD19 depleted allogeneic HSCT compared to T cell replete HSCT.

A H G Stuut et al.PubMed ↗Publisher ↗

No numbers read from the abstract.